Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells

Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells

Abstract Background To clarify the effect of human umbilical cord-derived mesenchymal stem cell (hUC-MSCs) treatment on colitis and to explore the role of CD5+ B cells in MSC therapy. Methods The trinitrobenzenesulfonic acid (TNBS)-induced colitis mouse model was used. HUC-MSCs were transferred peri...

Full description

Bibliographic Details
Main Authors: Kang Chao, Shenghong Zhang, Yun Qiu, Xiaoyong Chen, Xiaoran Zhang, Chuang Cai, Yanwen Peng, Ren Mao, Meirav Pevsner-Fischer, Shomron Ben-horin, Eran Elinav, Zhirong Zeng, Baili Chen, Yao He, Andy Peng Xiang, Minhu Chen
Format: Article
Language:English
Published: BMC 2016-08-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stem cells
Colitis
Crohn’s disease
B regulatory cell
T helper cell
Online Access:http://link.springer.com/article/10.1186/s13287-016-0376-2

Internet

http://link.springer.com/article/10.1186/s13287-016-0376-2

Similar Items